Skip to main content
Top
Published in: Medical Microbiology and Immunology 2/2011

01-05-2011 | Original Investigation

Monitoring prevalence of varicella-zoster virus clades in Germany

Authors: A. Sauerbrei, J. Stefanski, A. Philipps, A. Krumbholz, R. Zell, P. Wutzler

Published in: Medical Microbiology and Immunology | Issue 2/2011

Login to get access

Abstract

The global surveillance of varicella-zoster virus (VZV) clades is an important tool for investigation into viral evolution, host-virus interactions, role of immigration and travel for importation of viral strains as well as possible recombination events between wild- and vaccine-type VZV strains. In this prospective study, comprehensive data on the current distribution of VZV clades in Germany were collected. VZV strains from 213 patients with varicella and 109 with zoster were genotyped using the scattered single-nucleotide polymorphism method on the basis of sequencing open reading frames 1, 21, 22, 37, 50, 54 and 60. In varicella, clade 3 was detected in 45.5%, clade 1 in 30.0%, clade 5 in 21.1% and clade 2 in 0.9% of the cases. The analysis of zoster strains revealed clade 3 in 50.5%, clade 1 in 46.8%, clade 2 and clade 4 in 0.9% of the cases each. Five strains from varicella and one strain from zoster could not be attributed to any of the major and provisional VZV clades. Statistical analysis verified significantly lower frequency of clade 1 and significantly higher frequency of clade 5 in patients with varicella compared to zoster. In addition, varicella patients with clade 5 strains were significantly younger than the patients with clade 3. In conclusion, almost one half of VZV infections in Germany were caused currently by VZV clade 3. In primary VZV infection, nearly 20% of clade 1 has been replaced by clade 5 that might spread more effectively in the population than the European VZV clades.
Literature
1.
go back to reference Gershon A, Mervish N, LaRussa P, Steinberg S, Lo SH, Hodes D, Fikrig S, Bonagura V, Bakshi S (1997) Varicella-zoster virus infection in children with underlying HIV infection. J Infect 176:1496–1500CrossRef Gershon A, Mervish N, LaRussa P, Steinberg S, Lo SH, Hodes D, Fikrig S, Bonagura V, Bakshi S (1997) Varicella-zoster virus infection in children with underlying HIV infection. J Infect 176:1496–1500CrossRef
2.
go back to reference Salleras L, Domínguez A, Plans P, Costa J, Cardeñosa N, Torner N, Plasència A (2008) Seroprevalence of varicella zoster virus infection in child and adult population of Catalonia (Spain). Med Microbiol Immunol 197:329–333PubMedCrossRef Salleras L, Domínguez A, Plans P, Costa J, Cardeñosa N, Torner N, Plasència A (2008) Seroprevalence of varicella zoster virus infection in child and adult population of Catalonia (Spain). Med Microbiol Immunol 197:329–333PubMedCrossRef
3.
go back to reference Wicker S, Rabenau HF, Gottschalk R, Doerr HW, Allwin R (2007) Seroprevalence of vaccine preventable and blood transmissible viral infections (measles, mumps, rubella, polio, HBV, HCV and HIV) in medical students. Med Microbiol Immunol 196:145–150PubMedCrossRef Wicker S, Rabenau HF, Gottschalk R, Doerr HW, Allwin R (2007) Seroprevalence of vaccine preventable and blood transmissible viral infections (measles, mumps, rubella, polio, HBV, HCV and HIV) in medical students. Med Microbiol Immunol 196:145–150PubMedCrossRef
4.
go back to reference Wutzler P, Färber I, Wagenpfeil S, Bisanz H, Tischer A (2001) Seroprevalence of varicella-zoster virus in the German population. Vaccine 20:121–124PubMedCrossRef Wutzler P, Färber I, Wagenpfeil S, Bisanz H, Tischer A (2001) Seroprevalence of varicella-zoster virus in the German population. Vaccine 20:121–124PubMedCrossRef
5.
go back to reference Lokeshwar MR, Agrawal A, Subbarao SD, Chakraborty MS, Ram Prasad AV, Weil J, Bock HL, Kanwal S, Shah RC, Shah N (2000) Age related seroprevalence of antibodies to varicella in India. Indian Pediatr 37:714–719PubMed Lokeshwar MR, Agrawal A, Subbarao SD, Chakraborty MS, Ram Prasad AV, Weil J, Bock HL, Kanwal S, Shah RC, Shah N (2000) Age related seroprevalence of antibodies to varicella in India. Indian Pediatr 37:714–719PubMed
6.
go back to reference Barrett-Muir W, Scott FT, Aaby P, John J, Matondo P, Chaudhry QL, Siqueira M, Poulsen A, Yamanishi K, Breuer J (2003) Genetic variation of varicella-zoster virus: evidence for geographical separation of strains. J Med Virol 70:S42–S47PubMedCrossRef Barrett-Muir W, Scott FT, Aaby P, John J, Matondo P, Chaudhry QL, Siqueira M, Poulsen A, Yamanishi K, Breuer J (2003) Genetic variation of varicella-zoster virus: evidence for geographical separation of strains. J Med Virol 70:S42–S47PubMedCrossRef
7.
go back to reference Loparev V, Martro E, Rubtcova E, Rodrigo C, Piette JC, Caumes E, Vernant JP, Schmid DS, Fillet AM (2007) Toward universal varicella-zoster virus (VZV) genotyping: diversity of VZV strains from France and Spain. J Clin Microbiol 45:559–563PubMedCrossRef Loparev V, Martro E, Rubtcova E, Rodrigo C, Piette JC, Caumes E, Vernant JP, Schmid DS, Fillet AM (2007) Toward universal varicella-zoster virus (VZV) genotyping: diversity of VZV strains from France and Spain. J Clin Microbiol 45:559–563PubMedCrossRef
8.
go back to reference Quinlivan M, Hawrami K, Barrett-Muir W, Aaby P, Arvin A, Chow VT, John TJ, Matondo P, Peiris M, Poulsen A, Siqueira M, Takahashi M, Talukder Y, Yamanishi K, Leedham-Green M, Scott FT, Thomas SL, Breuer J (2002) The molecular epidemiology of varicella-zoster virus: evidence for geographic segregation. J Infect Dis 186:888–894PubMedCrossRef Quinlivan M, Hawrami K, Barrett-Muir W, Aaby P, Arvin A, Chow VT, John TJ, Matondo P, Peiris M, Poulsen A, Siqueira M, Takahashi M, Talukder Y, Yamanishi K, Leedham-Green M, Scott FT, Thomas SL, Breuer J (2002) The molecular epidemiology of varicella-zoster virus: evidence for geographic segregation. J Infect Dis 186:888–894PubMedCrossRef
9.
go back to reference Bonanni P, Breuer J, Gershon A, Gershon M, Hryniewicz W, Papaevangelou V, Rentier B, Rümke H, Sadzot-Delvaux C, Senterre J, Weil-Oliver C, Wutzler P (2009) Varicella vaccination in Europe—taking the practical approach. BMC Medicine 7:26PubMedCrossRef Bonanni P, Breuer J, Gershon A, Gershon M, Hryniewicz W, Papaevangelou V, Rentier B, Rümke H, Sadzot-Delvaux C, Senterre J, Weil-Oliver C, Wutzler P (2009) Varicella vaccination in Europe—taking the practical approach. BMC Medicine 7:26PubMedCrossRef
10.
go back to reference Uebe B, Sauerbrei A, Burdach S, Horneff G (2002) Herpes zoster by reactivated vaccine varicella-zoster virus in a healthy child. Eur J Pediatr 161:442–444PubMedCrossRef Uebe B, Sauerbrei A, Burdach S, Horneff G (2002) Herpes zoster by reactivated vaccine varicella-zoster virus in a healthy child. Eur J Pediatr 161:442–444PubMedCrossRef
11.
go back to reference Quinlivan M, Breuer J (2006) Molecular studies of varicella-zoster virus. Rev Med Virol 16:225–250PubMedCrossRef Quinlivan M, Breuer J (2006) Molecular studies of varicella-zoster virus. Rev Med Virol 16:225–250PubMedCrossRef
12.
go back to reference Breuer J, Grose C, Norberg P, Tipples G, Schmid DS (2010) A proposal for a common nomenclature for viral clades that form the species varicella-zoster virus: summary of VZV Nomenclature Meeting 2008, Barts and the London School of Medicine and Dentistry. J Gen Virol 91:821–828PubMedCrossRef Breuer J, Grose C, Norberg P, Tipples G, Schmid DS (2010) A proposal for a common nomenclature for viral clades that form the species varicella-zoster virus: summary of VZV Nomenclature Meeting 2008, Barts and the London School of Medicine and Dentistry. J Gen Virol 91:821–828PubMedCrossRef
13.
go back to reference Sauerbrei A, Zell R, Philipps A, Wutzler P (2008) Genotypes of varicella-zoster virus wild-type strains in Germany. J Med Virol 80:1123–1130PubMedCrossRef Sauerbrei A, Zell R, Philipps A, Wutzler P (2008) Genotypes of varicella-zoster virus wild-type strains in Germany. J Med Virol 80:1123–1130PubMedCrossRef
14.
go back to reference Puchhammer-Stöckl E, Popow-Kraupp T, Heinz FX, Mandl CW, Kunz C (1991) Detection of varicella-zoster virus DNA by polymerase chain reaction in the cerebrospinal fluid of patients suffering neurological complications associated with chicken pox or herpes zoster. J Clin Microbiol 29:1513–1516PubMed Puchhammer-Stöckl E, Popow-Kraupp T, Heinz FX, Mandl CW, Kunz C (1991) Detection of varicella-zoster virus DNA by polymerase chain reaction in the cerebrospinal fluid of patients suffering neurological complications associated with chicken pox or herpes zoster. J Clin Microbiol 29:1513–1516PubMed
15.
go back to reference Sauerbrei A, Eichhorn U, Schacke M, Wutzler P (1999) Laboratory diagnosis of herpes zoster. J Clin Virol 14:31–36PubMedCrossRef Sauerbrei A, Eichhorn U, Schacke M, Wutzler P (1999) Laboratory diagnosis of herpes zoster. J Clin Virol 14:31–36PubMedCrossRef
16.
go back to reference Sauerbrei A, Philipps A, Zell R, Wutzler P (2007) Genotyping of varicella-zoster virus strains after serial passages in cell culture. J Virol Methods 145:80–83PubMedCrossRef Sauerbrei A, Philipps A, Zell R, Wutzler P (2007) Genotyping of varicella-zoster virus strains after serial passages in cell culture. J Virol Methods 145:80–83PubMedCrossRef
17.
go back to reference Sauerbrei A, Eichhorn U, Gawellek S, Egerer R, Schacke M, Wutzler P (2003) Characterisation of varicella-zoster virus strains in Germany and differentiation from the Oka vaccine strain. J Med Virol 71:313–319PubMedCrossRef Sauerbrei A, Eichhorn U, Gawellek S, Egerer R, Schacke M, Wutzler P (2003) Characterisation of varicella-zoster virus strains in Germany and differentiation from the Oka vaccine strain. J Med Virol 71:313–319PubMedCrossRef
18.
go back to reference Loparev VN, Rubtcova EN, Bostik V, Tzaneva V, Sauerbrei A, Robo A, Sattler-Dornbacher E, Hanovcova I, Stepanova V, Splino M, Eremin V, Koskiniemi M, Vankova OE, Schmid DS (2009) Distribution of varicella-zoster virus (VZV) wild type genotypes in northern and southern Europe: evidence for high conservation of circulating genotypes. Virology 383:216–225PubMedCrossRef Loparev VN, Rubtcova EN, Bostik V, Tzaneva V, Sauerbrei A, Robo A, Sattler-Dornbacher E, Hanovcova I, Stepanova V, Splino M, Eremin V, Koskiniemi M, Vankova OE, Schmid DS (2009) Distribution of varicella-zoster virus (VZV) wild type genotypes in northern and southern Europe: evidence for high conservation of circulating genotypes. Virology 383:216–225PubMedCrossRef
19.
go back to reference Ständige Impfkommission am Robert Koch-Institut (2004) Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut/Stand. Epidemiol Bull 30:235–250 Ständige Impfkommission am Robert Koch-Institut (2004) Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut/Stand. Epidemiol Bull 30:235–250
20.
go back to reference Schmidt-Chanasit J, Stürmer M, Hahn A, Schäd SG, Gross G, Ulrich RG, Heckel G, Doerr HW (2007) Novel genotyping approach for varicella-zoster virus strains from Germany. J Clin Microbiol 45:3540–3545PubMedCrossRef Schmidt-Chanasit J, Stürmer M, Hahn A, Schäd SG, Gross G, Ulrich RG, Heckel G, Doerr HW (2007) Novel genotyping approach for varicella-zoster virus strains from Germany. J Clin Microbiol 45:3540–3545PubMedCrossRef
21.
go back to reference Barrett-Muir W, Nichols R, Breuer J (2002) Phylogenetic analysis of varicella-zoster virus: evidence variation of varicella-zoster virus: evidence of intercontinental spread of genotypes and recombination. J Virol 76:1971–1979CrossRef Barrett-Muir W, Nichols R, Breuer J (2002) Phylogenetic analysis of varicella-zoster virus: evidence variation of varicella-zoster virus: evidence of intercontinental spread of genotypes and recombination. J Virol 76:1971–1979CrossRef
22.
go back to reference Carr MJ, McCormack GP, Crowley B (2004) Genetic variation in clinical varicella-zoster virus isolates collected in Ireland between 2002 and 2003. J Med Virol 73:131–136PubMedCrossRef Carr MJ, McCormack GP, Crowley B (2004) Genetic variation in clinical varicella-zoster virus isolates collected in Ireland between 2002 and 2003. J Med Virol 73:131–136PubMedCrossRef
23.
go back to reference Loparev VN, Gonzalez A, Deleon-Carnes M, Tipples G, Fickenscher H, Torfason EG, Schmid DS (2004) Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping. J Virol 78:8349–8358PubMedCrossRef Loparev VN, Gonzalez A, Deleon-Carnes M, Tipples G, Fickenscher H, Torfason EG, Schmid DS (2004) Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping. J Virol 78:8349–8358PubMedCrossRef
24.
go back to reference Wagenaar TR, Chow VT, Buranathai C, Thawatsupha P, Grose C (2003) The out of Africa model of varicella-zoster virus evolution: single nucleotide polymorphisms and private alleles distinguish Asian clades from European/North American clades. Vaccine 21:1072–1081PubMedCrossRef Wagenaar TR, Chow VT, Buranathai C, Thawatsupha P, Grose C (2003) The out of Africa model of varicella-zoster virus evolution: single nucleotide polymorphisms and private alleles distinguish Asian clades from European/North American clades. Vaccine 21:1072–1081PubMedCrossRef
25.
go back to reference Loparev VN, Rubtcova EN, Bostik V, Govil D, Birch CJ, Druce JC, Schmid DS, Croxson MC (2007) Identification of five major and two minor genotypes of varicella-zoster virus strains: a practical two-amplicon approach used to genotype clinical isolates in Australia and New Zealand. J Virol 81:12758–12765PubMedCrossRef Loparev VN, Rubtcova EN, Bostik V, Govil D, Birch CJ, Druce JC, Schmid DS, Croxson MC (2007) Identification of five major and two minor genotypes of varicella-zoster virus strains: a practical two-amplicon approach used to genotype clinical isolates in Australia and New Zealand. J Virol 81:12758–12765PubMedCrossRef
26.
go back to reference Schmidt-Chanasit J, Ölschläger S, Bialonski A, Heinemann P, Bleymehl K, Gross G, Günther S, Ulrich RG, Doerr HW (2009) Novel approach to differentiate subclades of varicella-zoster virus genotypes E1 and E2 in Germany. Virus Res 145:347–349PubMedCrossRef Schmidt-Chanasit J, Ölschläger S, Bialonski A, Heinemann P, Bleymehl K, Gross G, Günther S, Ulrich RG, Doerr HW (2009) Novel approach to differentiate subclades of varicella-zoster virus genotypes E1 and E2 in Germany. Virus Res 145:347–349PubMedCrossRef
27.
go back to reference Schmidt-Chanasit J, Olschläger S, Günther S, Govil D, Birch CJ, Druce JC, Schmid DS, Croxson MC (2008) Molecular analysis of varicella-zoster virus strains circulating in Tanzania demonstrating the presence of genotype M1. J Clin Microbiol 46:3530–3533PubMedCrossRef Schmidt-Chanasit J, Olschläger S, Günther S, Govil D, Birch CJ, Druce JC, Schmid DS, Croxson MC (2008) Molecular analysis of varicella-zoster virus strains circulating in Tanzania demonstrating the presence of genotype M1. J Clin Microbiol 46:3530–3533PubMedCrossRef
28.
go back to reference Sengupta N, Taha Y, Scott FT, Leedham-Green E, Quinlivan M, Breuer J (2007) Varicella-zoster virus genotypes in East London: a prospective study in patients with herpes zoster. J Infect Dis 196:1014–1020PubMedCrossRef Sengupta N, Taha Y, Scott FT, Leedham-Green E, Quinlivan M, Breuer J (2007) Varicella-zoster virus genotypes in East London: a prospective study in patients with herpes zoster. J Infect Dis 196:1014–1020PubMedCrossRef
29.
go back to reference Kelm S, Bierbach U, Sauerbrei A, Schuster V (2010) Herpes Zoster bei einem VZV-geimpften Kleinkind mit akuter myeloischer Leukämie: Nachweis des VZV-Oka-Impfstammes in den Zoster-Hauteffloreszenzen. Kinder- und Jugendmedizin 10:141–144 Kelm S, Bierbach U, Sauerbrei A, Schuster V (2010) Herpes Zoster bei einem VZV-geimpften Kleinkind mit akuter myeloischer Leukämie: Nachweis des VZV-Oka-Impfstammes in den Zoster-Hauteffloreszenzen. Kinder- und Jugendmedizin 10:141–144
30.
go back to reference LaRussa P, Lungu O, Hardy I, Gershon A, Steinberg SP, Silverstein S (1992) Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. J Virol 66:1016–1020PubMed LaRussa P, Lungu O, Hardy I, Gershon A, Steinberg SP, Silverstein S (1992) Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. J Virol 66:1016–1020PubMed
31.
go back to reference Loparev VN, Argaw T, Krause PR, Takayama M, Schmid DS (2000) Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62- based PCR. J Clin Microbiol 38:3156–3160PubMed Loparev VN, Argaw T, Krause PR, Takayama M, Schmid DS (2000) Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62- based PCR. J Clin Microbiol 38:3156–3160PubMed
32.
go back to reference Hambleton S, Gershon AA (2005) Preventing varicella-zoster disease. Clin Microb Rev 18:70–80CrossRef Hambleton S, Gershon AA (2005) Preventing varicella-zoster disease. Clin Microb Rev 18:70–80CrossRef
33.
go back to reference Lamberti C, Weller SK (1996) The herpes simplex virus type 1 UL6 protein is essential for cleavage and packaging but not for genomic inversion. Virology 15:403–407CrossRef Lamberti C, Weller SK (1996) The herpes simplex virus type 1 UL6 protein is essential for cleavage and packaging but not for genomic inversion. Virology 15:403–407CrossRef
34.
go back to reference Visalli R, Fairhurst J, Srinivas S, Hu W, Feld B, DiGrandi M, Curran K, Ross A, Bloom JD, van Zeijl M, Jones TR, O’Connell J, Cohen JI (2003) Identification of small molecule compounds that selectively inhibit varicella-zoster virus replication. J Virol 77:2349–2358PubMedCrossRef Visalli R, Fairhurst J, Srinivas S, Hu W, Feld B, DiGrandi M, Curran K, Ross A, Bloom JD, van Zeijl M, Jones TR, O’Connell J, Cohen JI (2003) Identification of small molecule compounds that selectively inhibit varicella-zoster virus replication. J Virol 77:2349–2358PubMedCrossRef
35.
go back to reference Toi CS, Dwyer DE (2010) Prevalence of varicella-zoster virus genotypes in Australia characterized by HRMA and ORF22 gene analyses. J Med Microbiol 59:935–940PubMedCrossRef Toi CS, Dwyer DE (2010) Prevalence of varicella-zoster virus genotypes in Australia characterized by HRMA and ORF22 gene analyses. J Med Microbiol 59:935–940PubMedCrossRef
36.
go back to reference Sergeev N, Rubtcova E, Chizikov V, Schmid DS, Loparev VN (2006) New mosaic subgenotype of varicella-zoster virus in the USA: VZV detection and genotyping by oligonucleotide-microarray. J Virol Methods 136:8–16PubMedCrossRef Sergeev N, Rubtcova E, Chizikov V, Schmid DS, Loparev VN (2006) New mosaic subgenotype of varicella-zoster virus in the USA: VZV detection and genotyping by oligonucleotide-microarray. J Virol Methods 136:8–16PubMedCrossRef
Metadata
Title
Monitoring prevalence of varicella-zoster virus clades in Germany
Authors
A. Sauerbrei
J. Stefanski
A. Philipps
A. Krumbholz
R. Zell
P. Wutzler
Publication date
01-05-2011
Publisher
Springer-Verlag
Published in
Medical Microbiology and Immunology / Issue 2/2011
Print ISSN: 0300-8584
Electronic ISSN: 1432-1831
DOI
https://doi.org/10.1007/s00430-010-0178-6

Other articles of this Issue 2/2011

Medical Microbiology and Immunology 2/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.